Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. Hologic deals stake in Procleix blood-screening biz to Grifols for $1.9B
Hologic said yesterday that it agreed to deal its stake in the Procleix blood-screening business it runs with Grifols for nearly $1.9 billion.
Hologic, which makes the Procleix line, said it’s selling its stake for $1.85 billion to Barcelona-based Grifols, which sells the molecular assays and instruments. Blood banks use the products to screen donated blood for viruses such as HIV, hepatitis C and B, West Nile and Zika. Read more
4. GI Dynamics raises $1.1m in private placement
GI Dynamics said today it raised approximately $1.1 million (AU $1.5 million) and announced an upcoming security purchase plan looking to raise an additional $732,006 (AU $987,910).
The Lexington, Mass.-based company raised funds through the sale of 69.9 million Chess depository interests, representing approximately 1.4 million shares of stock at 16¢ (AU 22¢) per share to investors in Australia “and other certain jurisdictions”. Read more
3. J&J’s LifeScan wins FDA clearance for WellDoc integration of blood glucose data
Johnson & Johnson subsidiary LifeScan said today it won FDA clearance for wireless integration of its OneTouch Verio Flex blood glucose monitoring system with WellDoc‘s FDA-approved BlueStar diabetes management system.
The OneTouch Verio Flex system is now cleared to automatically wirelessly transmit blood glucose monitoring data to WellDoc’s BlueStar system, which in turn provides patients with real-time feedback and virtual coaching based on patient specifics. The system also keeps the patient’s health care teams informed of their status for better decision making, the company said. Read more
2. Fresenius inks 5-year distro deal with Terumo to launch CATSmart in US
Fresenius business group Fresenius Kabi said today it inked a 5-year exclusive distribution deal with Terumo Corp. to launch Fresenius’ CATSmart autotransfusion system in the US.
Autotransfusion devices are designed to re-infuse a patient’s own lost blood during surgery. Fresenius said the CATSmart is its next-gen continuous autotransfusion system, featuring continuous-flow technology, 3 wash programs, an auto-start function and sensor for quick set up and automatic processing. Read more
1. FDA clears St. Jude Medical’s EnSite Precision heart map, Advisor FL catheter
St. Jude Medical said today that it won 510(k) clearance from the FDA for its EnSite Precision cardiac mapping system and the Advisor FL catheter used with it.
The Ensite cardiac mapping system is designed for use in ablation procedures to visualize and aid in catheter navigation in the heart, providing detailed anatomical models and maps, St. Jude said. The system is designed to aid in diagnosing arrhythmias, guiding therapy and providing expanded procedural options. Read more
